USTEKINUMAB

Course overview

USTEKINUMAB IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF A VARIETY OF INFLAMMATORY CONDITIONS, INCLUDING PSORIASIS, PSORIATIC ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE. IT IS IN THE MONOCLONAL ANTIBODY CLASS OF MEDICATIONS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR USTEKINUMAB AS A VALUABLE AGENT IN TREATING INFLAMMATORY DISEASE. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PSORIASIS, PSORIATIC ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE.